Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Acq. announced
Filed Chapter 11
Quarterly results
CC transcript
MiddleBrook Pharmaceuticals, Inc. (MBRKQ) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2012 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2011 SC 13G/A MiddleBrook Pharmaceuticals, Inc. reports a 0% stake in MiddleBrook Pharmaceuticals, Inc.
01/19/2011 8-K Quarterly results
01/07/2011 SC 13G MiddleBrook Pharmaceuticals, Inc. reports a 7.5% stake in Middlebrook Pharmaceuticals, Inc.
01/06/2011 8-K Bankruptcy or Receivership, Financial Statements and Exhibits
Docs: "Debtor's Modified Plan of Liquidation"
12/20/2010 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Monthly Operating Report for the Period from November 1, 2010 to November 30, 2010"
12/07/2010 4 Cole Brad (SVP, GC) has filed a Form 4 on MiddleBrook Pharmaceuticals, Inc.
Txns: Sold 19,900 shares @ $0.0785, valued at $1.6k
12/02/2010 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
11/22/2010 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Monthly Operating Report for the Period from October 1, 2010 to October 31, 2010"
11/22/2010 4 EGI-MBRK, L.L.C. (10% Owner) has filed a Form 4 on MiddleBrook Pharmaceuticals, Inc.
11/22/2010 SC 13D/A EGI-MBRK, L.L.C. has filed a Schedule 13D for MIDDLEBROOK PHARMACEUTICALS, INC.
11/10/2010 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Debtor's Plan of Liquidation",
"Disclosure Statement for the Debtor's Plan of Liquidation"
10/20/2010 8-K Form 8-K - Current report
09/20/2010 8-K Form 8-K - Current report
08/10/2010 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
08/05/2010 8-K Completion of Acquisition or Disposition of Assets, Cost Associated with Exit or Disposal Activities, Departure of Directors ...
Docs: "MiddleBrook Pharmaceuticals Completes Sale of Assets"
07/21/2010 8-K Acquisition/merger/asset purchase announced
Docs: "Monthly Operating Report for the Period from June 1, 2010 to June 30, 2010"
05/28/2010 25-NSE Form 25-NSE -
05/20/2010 8-K Form 8-K - Current report
05/07/2010 10-Q Quarterly Report for the period ended March 31, 2010
05/04/2010 8-K Filed for Chapter 11
Docs: "MiddleBrook Pharmaceuticals Files for Chapter 11 Bankruptcy Protection"
04/30/2010 10-K/A Annual Report for the period ended December 31, 2009 [amend]
04/30/2010 BW MiddleBrook Pharmaceuticals Files for Chapter 11 Bankruptcy Protection
04/12/2010 8-K Form 8-K - Current report
03/23/2010 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/23/2010 BW MiddleBrook Pharmaceuticals Announces Board of Directors Resignations
03/17/2010 BW MiddleBrook Pharmaceuticals Announces Expanded IncreaseRx® Promotion for MOXATAG®
03/16/2010 10-K Annual Report for the period ended December 31, 2009
03/15/2010 8-K Quarterly results
Docs: "Press Release issued March 12, 2010"
03/12/2010 BW MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results; Announces Reduction in Force; Engages Broadpoint Gleacher to Assist in the Evaluation of Strategic Options
12/21/2009 4 EGI-MBRK, L.L.C. (10% Owner) has filed a Form 4 on MiddleBrook Pharmaceuticals, Inc.
12/21/2009 SC 13D/A EGI-MBRK, L.L.C. has filed a Schedule 13D for MIDDLEBROOK PHARMACEUTICALS, INC.
12/03/2009 8-K Form 8-K - Current report
11/25/2009 4 BLYTH LORD JAMES (Director) has filed a Form 4 on MiddleBrook Pharmaceuticals, Inc.
Txns: Granted 500,000 options to buy @ $0.7, valued at $350k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy